SLC44A4 and malaria: There were five significant results for those with any_malaria versus never_malaria group: rs1800896– IL10-1082 (OR: 0.528, CI: 0.360–0.774; P = 0.0014), rs2706384 - IRF1 (OR: 1.881, 95% CI: 1.298–2.724; P = 0.0005), rs2242665 - CTL4 (OR: 0.595, 95% CI: 0.434–0.816; P = 0.0012), rs4986790 - TLR4 (OR: 0.274, 95% CI: 0.124–0.604; P = 0.0014) and rs909253 - LTA+252 (OR: 0.343, 95% CI: 0.182–0.647; P = 0.0009) (see Table 2).